Stifel Nicolaus raises its price target on Mednax (MD -0.5%) to $83 from $74 on the back of its...
Stifel Nicolaus raises its price target on Mednax (MD -0.5%) to $83 from $74 on the back of its investor day, saying it believes the company shows strong top-line and margin growth prospects for its American Anesthesiology division. It maintains a buy rating on the stock.
From other sites
at CNBC.com (Jul 29, 2013)
at CNBC.com (Jul 18, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs